By Sheri Kasprzak
New York, Oct. 19 - Stressgen Biotechnologies Corp. said it plans to raise up to C$2,625,000 in a private placement of units.
The offering includes up to 7.5 million units at C$0.35 each.
The units are comprised of one share and one-third of a warrant. The whole warrants allow for the purchase of another share at C$0.50 each for two years.
Placement agent Canaccord Capital Corp. has an over-allotment option for up to 5 million additional units.
Victoria, B.C.-based Stressgen is a biopharmaceutical company focused on the development of therapeutic vaccines for infectious diseases and cancer.
| Issuer: | Stressgen Biotechnologies Corp.
|
| Issue: | Units of one share and one-third of a warrant
|
| Amount: | C$2,625,000 (maximum)
|
| Units: | 7.5 million (maximum)
|
| Greenshoe: | For 5 million units
|
| Price: | C$0.35
|
| Warrants: | One third-share warrant per unit
|
| Warrant expiration: | Two years
|
| Warrant strike price: | C$0.50
|
| Placement agent: | Canaccord Capital Corp.
|
| Pricing date: | Oct. 19
|
| Stock price: | C$0.35 at close Oct. 18
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
